THIRD AMENDMENT TO THEFraction Iv-1 Paste Supply Agreement • February 25th, 2016 • Kamada LTD • Pharmaceutical preparations
FOURTH AMENDMENT TO THE EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • February 25th, 2016 • Kamada LTD • Pharmaceutical preparations
This FOURTH Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012, May 14th, 2013, and February 15, 2014 by and between Baxalta US Inc., having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “Baxalta”) and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “Kamada”) (the "Agreement") is entered into as of this 10th day of August, 2015 (the "Effective Date"). Baxalta and Kamada shall collectively be referred to as the “Parties”.
SECOND AMENDMENT TO THE TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • February 25th, 2016 • Kamada LTD • Pharmaceutical preparations
This Second Amendment to the Technology License Agreement dated August 23rd, 2010, and amended 14th of May, 2013, by and between Baxter Healthcare SA, a Swiss corporation organized under the laws of Switzerland, which was succeeded by Baxalta GmbH, a corporation organized under the laws of Switzerland (hereinafter “Baxalta”) and Kamada Ltd., a corporation organized under the laws of Israel (hereinafter “Kamada”) (the "Agreement") is entered into as of this 25th day of August, 2015 (the "Effective Date"). Baxalta and Kamada shall collectively be referred to as the “Parties”.
